Skip to main content
Fig. 6 | Experimental Hematology & Oncology

Fig. 6

From: Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

Fig. 6

Blocking Siglec-10 restores the anti-tumor activity of CD8+ T cells. a HCC single-cell suspension was incubated with isotype control or recombinant Siglec-10 Fc chimera. b After incubation with isotype or Siglec-10 Fc, Siglec-10+ TAMs were subjected to flow cytometry analysis. c, d After incubation with isotype or Siglec-10 Fc, CD8+ T cells were subjected to flow cytometry analysis to detect the expression of immune stimulatory (c) and inhibitory (d) molecules

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us